BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.116
-0.004 (-0.36%)
Nov 6, 2025, 4:54 PM CET
BioPorto Market Cap
BioPorto has a market cap or net worth of 507.4 million as of November 6, 2025. Its market cap has decreased by -36.85% in one year.
Market Cap
507.40M
Enterprise Value
468.77M
Revenue
35.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.12
Market Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 507.40M, an increase of 574.03%. That is a compound annual growth rate of 9.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 509.22M | -23.54% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | 1.08B | 110.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.34T |
| Coloplast | 138.56B |
| Genmab | 113.20B |
| Demant | 48.14B |
| ALK-Abelló | 45.08B |
| H. Lundbeck | 43.53B |
| Zealand Pharma | 33.59B |
| Ambu A/S | 22.16B |